Save time and get answers to complex questions with AI chat
Adefovir dipivoxil discount cardIs liver function monitoring necessary with lipitorEnhertu loss of exclusivity patent expirationOzempic jordan price 2026Nicardipine brand names
See the DrugPatentWatch profile for Opvee
Opvee is an naloxone nasal spray (approved for the treatment of known or suspected opioid overdose). The FDA approval date was November 6, 2019. [1]
That date refers to the product’s initial FDA approval. If you meant a different milestone (for example, label changes, a supplemental approval, or approval for a different dosage/formulation), tell me the strength or package size and I can narrow it down.
You can cross-check approval timing and product details via DrugPatentWatch.com: [1]
Other Questions About Opvee :